Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter | Zendy

Bramah N. Singh | Zendy; Stuart J. Connolly | Zendy; Harry J.G.M. Crijns | Zendy; DenisClaude Roy | Zendy; Peter R. Kowey | Zendy; Alessandro Capucci | Zendy; David Radzik | Zendy; Etienne Aliot | Zendy; Stefan H. Hohnloser | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter

Author(s) -

Bramah N. Singh,

Stuart J. Connolly,

Harry J.G.M. Crijns,

DenisClaude Roy,

Peter R. Kowey,

Alessandro Capucci,

David Radzik,

Etienne Aliot,

Stefan H. Hohnloser

Publication year - 2007

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa054686

Subject(s) - dronedarone , medicine , amiodarone , atrial fibrillation , atrial flutter , sinus rhythm , placebo , cardiology , antiarrhythmic agent , randomized controlled trial , clinical endpoint , anesthesia , heart disease , alternative medicine , pathology

Amiodarone is effective in maintaining sinus rhythm in atrial fibrillation but is associated with potentially serious toxic effects. Dronedarone is a new antiarrhythmic agent pharmacologically related to amiodarone but developed to reduce the risk of side effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research